Anna Tomlinson

Anna Tomlinson currently serves as the Chief Executive Officer at Cardiomyopathy UK, a position held since February 2025. Prior to this role, Anna was the Chief Communications Officer at LifeArc from December 2022 to December 2024 and the Chief Communications and Engagement Officer at Genomics England from October 2019 to November 2022. Anna has also held significant positions at Aetna as the Director, Global Head of Communications, and at InHealth as the Group Head of Marketing and Communications. Earlier in the career, Anna worked as Director at CCO Consultants, and as Vice President in marketing and communications at both Deutsche Bank and Credit Suisse First Boston. Anna holds a Master of Arts and a Bachelor of Arts from the University of Cambridge.